Chobani withdraws IPO plans after yogurt maker filed to go public in November

Chobani withdraws IPO plans after yogurt maker filed to go public in November


Packages of Chobani yogurt sit on the shelf at a grocery store July 7, 2021 in Washington, DC.

Drew Angerer | Getty Images

Chobani is withdrawing its plans for an initial public offering, according to a regulatory filing on Friday.

The food and beverage company filed to go public on the Nasdaq Exchange using the ticker “CHO” in November. Reuters reported that it was seeking a valuation of more than $10 billion.

related investing news

Raymond James downgrades Bed Bath & Beyond, says turnaround plan 'only kicks the can down the road'

CNBC Pro
Raymond James downgrades Bed Bath & Beyond, says turnaround plan ‘only kicks the can down the road’

But it’s been a rocky year for the stock market, leading to a drought of IPOs. In the second quarter, there were just 41 initial public offerings in the Americas, down 73% from the year-ago period, according to a recent EY report. Chobani joins payroll vendor Justworks, grocer Fresh Market and file-sharing company WeTransfer in cancelling its IPO this year.

In an emailed statement, Chobani cited current market conditions for the withdrawal.

“Our focus remains on strong execution and driving profitable growth, and we continue to be excited about the future of Chobani,” the statement said.

In recent years, Chobani has expanded its product portfolio beyond Greek yogurt, adding oat milk, coffee creamers, cold brew coffee and yogurt drinks to its roster.

In its filing to go public, the company said its revenue grew 5.2% to $1.4 billion from 2019 to 2020. However, its net loss more than tripled during that time, reaching $58.7 million, as it invested back into its business. Chobani said it planned to use a portion of the proceeds from the IPO to pay down debt. The company also said it would reorganize its corporate structure as part of the process.

In March, amid delays to its IPO, Chobani’s then-operating chief Peter McGuinness left for Impossible Foods, where he now serves as chief executive. Neil Saunders, managing director of GlobalData, said in a statement that the departures of top leaders like McGuinness have cast a shadow over Chobani, despite its strong sales growth.

“This have given the impression of serious disagreements at the top which is not exactly the message a business looking to go public wants to impart,” he said.

IPO market's drastic 2022 slowdown: What it means for banks



Source

Gen Z and social media are helping men’s makeup go mainstream. The beauty industry is trying to capitalize
Business

Gen Z and social media are helping men’s makeup go mainstream. The beauty industry is trying to capitalize

Pixdeluxe | E+ | Getty Images It often starts small. A dab of concealer. A tinted moisturizer. Maybe a brow gel that goes from borrowed to bought. For many men, like Daniel Rankin, makeup has transformed from something taboo into a tool to make them look less tired and more put together. “I remember thinking, […]

Read More
Stellantis scraps Jeep, Chrysler plug-in hybrid vehicles amid EV slowdown, recall
Business

Stellantis scraps Jeep, Chrysler plug-in hybrid vehicles amid EV slowdown, recall

The Camp Jeep outdoor terrain at the New York International Auto Shown on April 16, 2025. Danielle DeVries | CNBC DETROIT — Stellantis is scrapping its plug-in hybrid electric Jeep SUVs and Chrysler minivan amid slowing EV sales, quality issues and weakened federal fuel economy requirements. The automaker on Friday said the decision to end […]

Read More
Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight-loss pill
Business

Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight-loss pill

Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.  Smith Collection | Gado | Getty Images Amazon announced Friday it now offers Novo Nordisk‘s Wegovy weight-loss pill through its digital pharmacy. Novo Nordisk began rolling out an oral version of its injectable obesity drug Wegovy in the […]

Read More